SEC Form 4 · accession 0001209191-16-128854
Sierra Oncology, Inc. · SRRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Pelzer
Director
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001290149
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.06 | Jun 16, 2016 | A | 38,835 | A | — | Jun 16, 2026 | Common Stock | 38,835 | 38,835 | D |
Explanation of responses
- F1The option vests as to 8.333% of the total shares monthly, beginning on July 16, 2016, with 100% of the total shares vested and exercisable on June 16, 2017, subject to the reporting person's provision of service to the issuer on each vesting date.